Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 2: 8-Formamidocyclazocine analoguesWENTLAND, Mark P; XUFENG SUN; YINGCHUN YE et al.Bioorganic & medicinal chemistry letters (Print). 2003, Vol 13, Num 11, pp 1911-1914, issn 0960-894X, 4 p.Article

Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 6: Opioid receptor binding properties of cyclic variants of 8-carboxamidocyclazocineWENTLAND, Mark P; XUFENG SUN; COHEN, Dana J et al.Bioorganic & medicinal chemistry. 2008, Vol 16, Num 10, pp 5653-5664, issn 0968-0896, 12 p.Article

Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 5. Opioid receptor binding properties of N-((4'-phenyl)-phenethyl) analogues of 8-CACVANALSTINE, Melissa A; WENTLAND, Mark P; COHEN, Dana J et al.Bioorganic & medicinal chemistry letters (Print). 2007, Vol 17, Num 23, pp 6516-6520, issn 0960-894X, 5 p.Article

Selective protection and functionalization of morphine: Synthesis and opioid receptor binding properties of 3-amino-3-desoxymorphine derivativesWENTLAND, Mark P; WENHU DUAN; COHEN, Dana J et al.Journal of medicinal chemistry (Print). 2000, Vol 43, Num 19, pp 3558-3565, issn 0022-2623Article

Syntheses and opioid receptor binding properties of carboxamido-substituted opioidsWENTLAND, Mark P; RONGLIANG LOU; QUN LU et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 1, pp 203-208, issn 0960-894X, 6 p.Article

10-ketomorphinan and 3-substituted-3-desoxymorphinan analogues as mixed κ and μ opioid ligands: Synthesis and biological evaluation of their binding affinity at opioid receptorsAO ZHANG; WENNAN XIONG; BIDLACK, Jean M et al.Journal of medicinal chemistry (Print). 2004, Vol 47, Num 1, pp 165-174, issn 0022-2623, 10 p.Article

Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 4. Opioid receptor binding properties of 8-[N-(4'-phenyl)-phenethylcarboxamido] analogues of cyclazocine and ethylketocycalzocineWENTLAND, Mark P; VANALSTINE, Melissa; KUCEJKO, Robert et al.Journal of medicinal chemistry (Print). 2006, Vol 49, Num 18, pp 5635-5639, issn 0022-2623, 5 p.Article

Effects of the mixed-action κ/μ opioid agonist 8-carboxamidocyclazocine on cocaine- and food-maintained responding in rhesus monkeysSTEVENSON, Glenn W; WENTLAND, Mark P; BIDLACK, Jean M et al.European journal of pharmacology. 2004, Vol 506, Num 2, pp 133-141, issn 0014-2999, 9 p.Article

Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 7: Syntheses and opioid receptor properties of cyclic variants of cyclazocineWENTLAND, Mark P; QUN LU; GANORKAR, Rakesh et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 2, pp 365-368, issn 0960-894X, 4 p.Article

8-Carboxamidocyclazocine analogues: Redefining the structure-activity relationships of 2,6-methano-3-benzazocinesWENTLAND, Mark P; RONGLIANG LOU; YINGCHUN YE et al.Bioorganic & medicinal chemistry letters (Print). 2001, Vol 11, Num 5, pp 623-626, issn 0960-894XArticle

Syntheses of novel high affinity ligands for opioid receptorsWENTLAND, Mark P; LOU, Rongliang; BIDLACK, Jean M et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 8, pp 2289-2294, issn 0960-894X, 6 p.Article

Antinociceptive, brain-penetrating derivatives related to improgan, a non-opioid analgesicHOUGH, Lindsay B; NALWALK, Julia W; QUN LU et al.European journal of pharmacology. 2005, Vol 522, Num 1-3, pp 38-46, issn 0014-2999, 9 p.Article

3-Carboxamido analogues of morphine and naltrexone : Synthesis and opioid receptor binding propertiesWENTLAND, Mark P; RONGLIANG LOU; DEHNHARDT, Christoph M et al.Bioorganic & medicinal chemistry letters (Print). 2001, Vol 11, Num 13, pp 1717-1721, issn 0960-894XArticle

Redefining the structure―activity relationships of 2,6-methano-3-benzazocines. Part 8. High affinity ligands for opioid receptors in the picomolar K_i range: Oxygenated N-(2-[1,1'-biphenyl]-4-ylethyl) analogues of 8-CACWENTLAND, Mark P; JO, Sunjin; GARGANO, Joseph M et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 24, pp 7340-7344, issn 0960-894X, 5 p.Article

Brain P450 epoxygenase activity is required for the antinociceptive effects of improgan, a nonopioid analgesicHOUGH, Lindsay B; NALWALK, Julia W; PHILLIPS, James G et al.Pain (Amsterdam). 2011, Vol 152, Num 4, pp 878-887, issn 0304-3959, 10 p.Article

Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 3: 8-Thiocarboxamido and 8-thioformamido derivatives of cyclazocineWENTLAND, Mark P; XUFENG SUN; YIGONG BU et al.Bioorganic & medicinal chemistry letters (Print). 2005, Vol 15, Num 10, pp 2547-2551, issn 0960-894X, 5 p.Article

Synthesis and opioid receptor binding properties of a highly potent 4-hydroxy analogue of naltrexoneWENTLAND, Mark P; QUN LU; RONGLIANG LOU et al.Bioorganic & medicinal chemistry letters (Print). 2005, Vol 15, Num 8, pp 2107-2110, issn 0960-894X, 4 p.Article

Syntheses and opioid receptor binding affinities of 8-amino-2,6-methano-3-benzazocinesWENTLAND, Mark P; YINGCHUN YE; BIDLACK, Jean M et al.Journal of medicinal chemistry (Print). 2003, Vol 46, Num 5, pp 838-849, issn 0022-2623, 12 p.Article